Validation and prognostic value of EZ-ALBI score in patients with intermediate-stage hepatocellular carcinoma treated with trans-arterial chemoembolization

Abstract Background Heterogeneity of liver function and tumor burden in intermediate-stage hepatocellular carcinoma (HCC) results in different outcomes after transarterial chemoembolization (TACE). Easy albumin-bilirubin (EZ-ALBI), a simplified albumin-bilirubin (ALBI) score, has recently been propo...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Prooksa Ananchuensook, Supachaya Sriphoosanaphan, Sirinporn Suksawatamnauy, Nipaporn Siripon, Nutcha Pinjaroen, Nopavut Geratikornsupuk, Stephen J. Kerr, Kessarin Thanapirom, Piyawat Komolmit
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	BMC 2022-06-01
סדרה:	BMC Gastroenterology
נושאים:	Easy albumin-bilirubin score Intermediate-stage hepatocellular carcinoma Trans-arterial chemoembolization Overall survival
גישה מקוונת:	https://doi.org/10.1186/s12876-022-02366-y
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!